Background. Usually both hypothyroidism and hyperthyroidism are related to the cardiovascular and cerebrovascular disease development. The relationship between subclinical hypothyroidism has been widely investigated but the findings remain controversial. The aim of the present study was to evaluate the lipid profile in patients with subclinical hypothyroidism (SHypo) in comparison to controls and to determine the association of SHypo and dyslipidemia in attempt to find importance of small dense low-density lipoprotein cholesterol (sdLDL-C) in atherosclerosis.
INTRODUCTION
Subclinical hypothyroidism (SHypo) is type of thyroid failure which is characterized by mildly elevated thyroid stimulating hormone (TSH) and normal serum levels of peripheral thyroid hormones. SHypo occurs in 3% to 8% of the general population, it is more common in women than in men, and its prevalence increases with age. Patients with SHypo are asymptomatic or have only mild, non-specific symptoms of hypothyroidism, such as constipation and nausea [1, 2] .
Although thyroid hormones have an impact on lipid metabolism, connection between subclinical hypothyroidism, dyslipidemia and increased risk for atherosclerosis is still a matter of debate [3, 4] . It is known that LDL-C plays an important role in the development of atherosclerosis, but there is more evidence which highlights the importance of its qualitative composition. There are two distinct LDL subclass phenotypes: phenotype A, with a larger buoyant LDL subfraction, and phenotype B, with smaller and denser LDL subfraction. These small, dense low-density lipoprotein cholesterol (sdLDL-C) particles have been recognized as more atherogenic due to their better penetration into the arterial wall, their lower binding affinity for the LDL receptor, their prolonged plasma half-life and lower resistance to oxidative stress compared to large buoyant LDL-C [5] [6] [7] [8] . Some prospective studies have demonstrated an association between phenoltype B (sdLDL-C) and the risk of coronary heart disease (CHD) [9, 10] . Several observational studies investigated the relationship between SHypo, dyslipidaemia and the risk of CHD with heterogeneous results [11] [12] [13] [14] [15] [16] [17] [18] [19] .
The aim of the present study was to evaluate the lipid profile in patients with subclinical hypothyroidism (SHypo) in comparison to controls and to determine the association of SHypo and dyslipidemia in an attempt to find importance of small dense low-density lipoprotein cholesterol (sdLDL-C) in the process of atherosclerosis. Volunteers, 36-newly diagnosed SHypo female patients aged 30-70 years and 64 aged matched euthyroid healthy female controls were included in the study according to the inclusion and exclusion criteria mentioned below. The history of the current illness, medication, menopausal period, pregnancy, family history (previous stroke or ischemic heart disease) and alcohol consumption and cigarette smoking were noted in a previously compiled form. Body weight and height were measured in kilograms (kg) and meters (m). The body mass index (BMI) was calculated as the body mass divided by the square of the body height, and is universally expressed in units of kg/m 2 . BMI from 18.5 up to 24.99 indicated optimal weight, from 25 up to 30 indicated the person was overweight, and from 30 upwards suggested the person was obese. BMI lower than 18.5 suggested the person was underweight [20] .
MATERIAL AND METHODS

This study was conducted in General Hospital
DEFINITION OF SUBCLINICAL HYPOTHYROIDISM
Diagnosis of SHypo was based on the finding of high TSH levels associated with normal free thyroxine (fT4) levels. Wiersinga subdivided SHypo into grade IA (TSH>4.0 to10mU/L) and grade IB (≥ 10 mU/L) [2] . Croatian Thyroid Society Guidelines for Rational Detection of Thyroid Dysfunction defined subclinical hypothyroidism if fT4 is normal with mildly elevated TSH (5-10 mU/lL) [21] . In this study we took the reference ranges from our laboratory that had previously been standardized as follows: TSH: 0.35-4.9 mlU/L and fT4:9-19 pmol/L, therefore for subclinical hypothyroidism we took TSH value range 4.9-10 mlU/L. Exclusion criteria: 1) Previously diagnosed thyroid disease (hypothyreosis, hyperthyreosis, thyroidectomy), 2) Diabetes mellitus, 3) Polycystic ovary syndrome, ovariectomy, 4) Renal and hepatic dysfunction, 5) Heart failure, 6) Stroke or ischemic heart disease, 7) Other systemic disease, 8) Primary or secondary dyslipidemia, 9) Cancer, 10) Subjects receiving drugs known to affect the thyroid or lipid metabolism (hypolipidemic drugs, oral contraceptives or hormone replacement therapy including thyroxine supplements, amiodarone, etc.), 11) Pregnancy.
The subjects were selected from the cases referred to our Biochemistry laboratory by other departments (Internal medicine, Gynecology, Neurology) requesting for thyroid profile, suspecting different thyroid disorders. Based on the results of thyroid profile, those patients with elevated serum TSH levels (between 4.9 and 10 mlU/L) with normal fT4 levels (9-19 pmol/L) were diagnosed with subclinical hypothyroidism. Later in these patients fasting lipid profile and high-sensitivity C-reactive protein (hs-CRP) were estimated. Controls were age matched healthy euthyroid female subjects ( Figure 1 ).
LABORATORY PROCEDURES
After 12 hours of overnight fasting, blood samples were collected from all participants for biochemical parameters measurement. Blood samples were centrifuged within 30 minutes at 3000 rpm for 5 min and serum was separated. The sera were stored at -20°C, and for sdLDL-C at -80°C until assayed.
Serum fT4 and TSH levels were estimated using Chemiluminescent Microparticle Immunoassay (CMIA) technology with commercial kits (ARCHI-TECT) on ARCHITECT i1000SR Immunoassay Analyzer. The normal range for TSH is 0.35-4.9 mlU/L, and for fT4 is 9-19 pmol/L. Serum levels of total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL-C) were determined by enzymatic colorimetric assay with commercial kits (Beckman Coulter) on Beckman Coulter Analyzer (Recommended values for TC: < 5.0 mmol/L, TG < 1.7 mmol/L, HDL-C > 1.2 mmol/L, LDL-C < 3.0 mmol/L). Serum levels of hs-CRP were measured by a latex-enhanced turbidimetric immunoassay method using hs-CRP Latex reagents (Beckman Coulter) on Beckman Coulter Analyzer. The normal range for hs-CRP is 0.0-5.0 mg/L. Serum levels of sdLDL-C were measured using a sdLDL-EX "SEIKEN" test -spectrophotometric assay with commercial kits (Randox). Reference intervals for sdLDL for women -younger group (21- Statistical analyses were performed using Statistica, version 10 (StatSoft Inc., Tulsa, OK, USA). Quantitative variables were tested for normality using the Kolmogorov-Smirnov test and described with appropriate descriptive statistics measures. Difference in distribution of age between two groups was analysed using Mann-Whitney U test for independent groups. Distributions of dichotomised parameters in two groups were presented as absolute frequencies and analysed using Pearson's χ 2 test. Odds ratio was used as a measure of association between thyroid status and level of some lipid status parameters.
Required sample size for Pearson's χ 2 test with one degree of freedom, effect size = 0.5, power of test = 0.8 at significance level 0.05 was 32.
Results were interpreted at 5% significance level.
RESULTS
In this study 100 female subjects participated ranging from 30-70 years. The median age was 50 years. Central tendency and dispersion measures of quantitative variables are shown in Table 1 . The median of TC was 5.6 mmol/L, of TG was 1.2 mmol/L and of HDL was 1.5 mmol/L. Median value of LDL-C was 3.5 mmol/L and of sdLDL-C 0.8 mmol/L. Median value of TSH was 2.9 mlU/L and median of fT4 was 13 pmol/L. Median of CRP was 1.3 mg/L and of BMI 25.9 mg/L. Half of the subjects were in postmenopausal period, with median of the period 6 years (0-33 years). 60 subjects were overweight or obese (Table 1) .
Of the 100 subjects, 77 subjects had elevated value of total cholesterol (> 5 mmol/L), 17 subjects had elevated value of triglycerides (> 1.7 mmol/L), 16 subjects had reduced value of HDL < 1.2 mmol/L and 18 subjects had elevated value of sdLDL-C (Elevated value of sdLDL-C was defined for women -younger group (21-54 years) > 1.099 mmol/L, older group (55-75 years) > 1.259 mmol/L) (Figure 2) .
Of the 100 female subjects included in the study, 36 met the criteria for the group with subclinical hypothyroidism, whereas 64 met the criteria for the control group. 9 subjects had elevated hs-CRP. 5 subjects consumed alcoholic drink (more than one alcoholic beverage per week), and the 13 subjects were cigarette smokers. 42 subjects had positive family history of CHD (coronary heart disease: myocardial infarction or angina pectoris), or CVD (cerebrovascular disease: previous stroke or TIA). 36 subjects were previously diagnosed with hypertension and use antihypertensive drugs (Figure 2) .
Distribution of subjects according to the lipid status parameters, CRP and BMI between SHypo and control group are shown in Table 2 . Parameters were dichotomised into high or low, based on the criteria described in Material and methods paragraph.
Differences in distribution of subjects between SHypo and control group were confirmed for two parameters of lipid status, between SHypo and control group, higher sdLDL-C and TG > 1.7. Elevated levels of sdLDL-C and triglycerides are more common in SHypo group than in control (euthyroid) group. On the other hand, for other parameters TC, HDL, LDL as well as for CRP, and BMI no significant differences were observed. Note: TSH = Thyroid-stimulation hormone, fT4 = Free thyroxine, TC = Total cholesterol, HDL = High density lipoprotein, LDL = Low density lipoprotein, sdLDL-C = small dense low density lipoprotein cholesterol, TG = Triglyceride, hs-CRP = high sensitivity C-reactive protein, BMI: Body mass index. 
DISCUSSION
In the current study, we investigated the relationship between subclinical hypothyroidism and dyslipidemia in comparison with plasma levels of TSH, fT4, TC, TG, HDL, LDL, hs-CRP and sdLDL-C using a newly automated homogeneous sdLDL-C assay. Our data showed differences in lipid status between SHypo and control group. Subjects with SHypo had significantly higher level of sdLDL-C and TG compared with control (euthyroid) group. On the other hand, for other parameters TC, HDL, LDL, hs-CRP, and BMI no significant differences were observed between these two groups.
Luboshitzky et al. also supported the findings of our study. They have concluded that SHypo in middle-aged women is associated with hypertension, hypertriglyceridemia and elevated TC/HDL-C ratio [22] . Another study has indicated that SHypodyslipidemia may also be accompanied by increased TG levels [23] . Tourner et al. have reported that the TG concentrations of SHypo patients are higher than of control subjects [24] .
It is known that SHypo is associated with some functional cardiac abnormalities, such as left ventricular diastolic dysfunction, vascular abnormalities -increased vascular resistance, arterial stiffness, endothelial dysfunction and atherosclerosis [25] . Based on these findings hypothyroid patients tend to have higher CHD risk. Some studies investigated connection between SHypo and dyslipidemia with heterogeneous results. In a crosssectional study of 1149 women aged ≥ 55 years and in large studies subjects with subclinical hypothyroidism had a significantly higher prevalence of CHD than in euthyroid subjects [14, 26] . The initial analysis of the Whickham Survey found no association between autoimmune thyroid disease and SHypo over 20 years of follow-up, but re-analysis of the data, looking specifically at individuals with SHypo found an increase in CHD events and mortality [27] . On the other hand, a survey of 3233 older individuals did not show a significant difference in the prevalence of CHD, stroke, or peripheral artery disease between SHypo and euthyroid subjects [25, 28] . In the EPIC-Norfolk prospective study significantly increased concentrations of TC, LDL-C and TG were found in SHypo women, but despite the association between thyroid hormone levels and cardiovascular risk factors, thyroid status was not statistically significantly associated with the risk of future CHD or all-cause mortality in this large cohort [19] .
In hypothyroidism, lipoprotein lipase activity in the adipose tissue has been found normal or decreased, which results in the decrease of hepatic lipase activity and clearance of triglyceride-rich lipoproteins and leads to normal or increased levels of TG [3, 4, 29, 30] .
Atherogenic dyslipidemia is one of the most important factors of association of subclinical hypothyroidism and CHD [25] . LDL-C plays an important role in development of atherosclerosis, but it has been shown that some patients with a history of CHD had normal LDL which highlights the importance of determination of its qualitative composition.
There are a limited number of reports which investigated the relationships between subclinical hypothyroidism and sdLDL-C. In most previous studies LDL subclass measurements are based on different principles: gradient gel electrophoresis, nuclear magnetic resonance (NMR), spectroscopy and analytical ultracentrifugation. All of these methods required specialized skills and equipment, and thus are not suitable for use in general clinical practice. In this study we used a direct, homogeneous method for the quantification of sdLDL-C, a modified photometric test procedure which is commercially available, fully applicable to an automated chemistry analyzer without manual pretreatment of the sample, reducing the assay time to 10 min, and suitable for use in general clinical practice [5] .
Results of Abbas et al.'s study supported an independent association between LDL particle size phenotype, plasma TG and thyroid status [26] . In another study that investigated overt hypothyroid patients, no significant discordance in percentages of B phenotype (predominance of sdLDL-C) compared to the controls was found [30] . These conflicting reports in the literature may be a result of differences in sex and age of participating patients, differences in populations studied, the degree and duration of subclinical hypothyroidism, different definition of subclinical hypothyroidism, depending which was under the limit values for TSH, as well as differences in study design.
CONCLUSION
Our data showed that the SHypo is associated with some lipid abnormalities, including higher levels of serum TG and sdLDL-C. Namely, sdLDL-C is a strong and independent predictor of risk of CVD. Therefore, based on these results it can be concluded that careful screening of patients with SHypo, which is necessary to determine the lipid status, including the determination of qualitative characteristics of LDL particle, i.e., serum sdLDL-C, with the aim of timely treatment of SHypo and dyslipidemia and prevention of the development of atherosclerosis and potential complications such as cardiovascular and cerebrovascular diseases.
However, further studies are needed with larger population size and a "follow-up" period to monitor subjects and include those taking substitution hormone therapy (if therapy was introduced). 
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